NRNP 6635 Week 2 Psychopathology and Diagnostic Reasoning Discussion

Discussion: The Psychiatric Evaluation and Evidence-Based Rating Scales

Assessment tools have two primary purposes: 1) to measure illness and diagnose clients, and 2) to measure a client’s response to treatment. Often, you will find that multiple assessment tools are designed to measure the same condition or response. Not all tools, however, are appropriate for use in all clinical situations. You must consider the strengths and weaknesses of each tool to select the appropriate assessment tool for your client. For this Discussion, as you examine the assessment tool assigned to you by the Course Instructor, consider its use in psychotherapy.

ORDER A CUSTOMIZED, PLAGIARISM-FREE PAPER HERE

Good News For Our New customers . We can write this assignment for you and pay after Delivery. Our Top -rated medical writers will comprehensively review instructions , synthesis external evidence sources(Scholarly) and customize a quality assignment for you. We will also attach a copy of plagiarism report alongside and AI report. Feel free to chat Us

To Prepare:

Review this week’s Learning Resources and reflect on the insights they provide regarding psychiatric assessment and diagnosis.
Consider the elements of the psychiatric interview, history, and examination.
Consider the assessment tool assigned to you by the Course Instructor.

By Day 3 of Week 2

Post a brief explanation of three important components of the psychiatric interview and why you consider these elements important. Explain the psychometric properties of the rating scale you were assigned. Explain when it is appropriate to use this rating scale with clients during the psychiatric interview and how the scale is helpful to a nurse practitioner’s psychiatric assessment. Support your approach with at least 3 scholarly, peer reviewed sources from evidence-based literature. Utilize SafeAssign Drafts for originality report.

Assessment tool/rating scale you will refer to write discussion board

*PTSD Checklist (PCL)

Learning Resources

https://video.alexanderstreet.com/embed/diagnostic-criteria

https://www.youtube.com/watch?v=U5KwDgWX8L8

https://www.youtube.com/watch?v=IRiCntvec5U

ORDER A CUSTOMIZED, PLAGIARISM-FREE PAPER HERE

Discussion: The Psychiatric Evaluation and Evidence-Based Rating Scales

The three crucial components of a psychiatric interview are Psychiatric history, Substance use and abuse history, and mental status exam (MSE). The psychiatric history is considered essential because it provides the clinician with a perspective on the history of a client’s current illness and symptoms by comparing the findings with previous disorders and treatments (Savander et al., 2021). Substance use and abuse history is important because it enables the clinician to understand the role of substances in an individual’s overall life. Besides, the information is important to identify other mental health comorbidities associated with substance abuse like attention deficit disorder, depression, anxiety disorders, and post-traumatic stress disorder.

(Savander et al., 2021). Furthermore, the MSE is crucial in the psychiatric interview owing to the lack of clinically applicable diagnostic tests for most psychiatric diagnoses. Besides, psychiatric diagnoses are usually syndromes of patient history and objective data.

The PTSD Checklist (PCL) is a 20-item self-report assessment tool that evaluates the 20 symptoms of PTSD as per the DSM-5. The PCL is a self-report rating tool that patients can fill out before a clinic session and research participants for a study (Marx et al., 2021). It is brief, taking about 5-10 minutes to complete. The tool can screen patients for PTSD, make an interim PTSD diagnosis, and monitor changes in PTSD symptoms in patients during and after treatment (Marx et al., 2021). A structured clinical interview is considered the gold standard for diagnosing PTSD. However, the PCL can be used to give a provisional PTSD diagnosis when necessary.

The PCL is helpful to a PMHNP’s psychiatric assessment since it enables the NP to screen patients for PTSD symptoms in the domains of Re-experiencing, Avoidance, Negative alterations in cognition and mood, and Hyper-arousal (Roberts et al., 2021). It also helps the PMHNP assess changes in patients’ PTSD symptoms and thus determine if the treatment strategies being used are effective. As a result, it guides in developing patients’ treatment plans based on the results from the PCL.

References

Marx, B. P., Lee, D. J., Norman, S. B., Bovin, M. J., Sloan, D. M., Weathers, F. W., … & Schnurr, P. P. (2021). Reliable and clinically significant change in the clinician-administered PTSD Scale for DSM-5 and PTSD Checklist for DSM-5 among male veterans. Psychological Assessment. https://doi.org/10.1037/pas0001098

Roberts, N. P., Kitchiner, N. J., Lewis, C. E., Downes, A. J., & Bisson, J. I. (2021). Psychometric properties of the PTSD Checklist for DSM-5 in a sample of trauma exposed mental health service users. European journal of psychotraumatology, 12(1), 1863578. https://doi.org/10.1080/20008198.2020.1863578

Savander, E. È., Hintikka, J., Wuolio, M., & Peräkylä, A. (2021). The Patients’ Practises Disclosing Subjective Experiences in the Psychiatric Intake Interview. Frontiers in psychiatry, 12, 605760. https://doi.org/10.3389/fpsyt.2021.605760